FDA Inspection
Allay Pharmaceuticals, LLCAllay Pharmaceuticals, LLC – FDA Inspection, Nov 15, 2021
Record Details
This FDA Inspection record concerns Allay Pharmaceuticals, LLC, with an inspection on November 15, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Allay Pharmaceuticals, LLC
- Inspection Date
- November 15, 2021
- Product Type
- Drugs
View Company Profile
ID · 56dfe5eb-e249-4a5a-bde9-5193a86cb279
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1156679
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allay Pharmaceuticals, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 12, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allay Pharmaceuticals, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.